SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 92 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,385,000 | -2.3% | 1,403,149 | 0.0% | 0.17% | -2.4% |
Q2 2018 | $2,441,000 | -3.1% | 1,403,149 | +1.9% | 0.17% | -14.6% |
Q1 2018 | $2,519,000 | +8.4% | 1,376,708 | +32.2% | 0.20% | +32.7% |
Q4 2017 | $2,323,000 | +4.1% | 1,041,695 | +35.4% | 0.15% | +3.4% |
Q3 2017 | $2,231,000 | -69.1% | 769,140 | -52.6% | 0.14% | -70.6% |
Q2 2017 | $7,225,000 | -30.7% | 1,623,623 | -27.4% | 0.49% | -14.0% |
Q1 2017 | $10,428,000 | +9.2% | 2,237,701 | +42.7% | 0.57% | +24.0% |
Q4 2016 | $9,552,000 | +5.8% | 1,568,487 | -4.3% | 0.46% | +11.6% |
Q3 2016 | $9,028,000 | +48.2% | 1,638,410 | +2.2% | 0.41% | +23.6% |
Q2 2016 | $6,093,000 | +368.3% | 1,603,334 | +598.9% | 0.34% | +431.7% |
Q4 2015 | $1,301,000 | -27.8% | 229,420 | -32.5% | 0.06% | -27.6% |
Q3 2015 | $1,802,000 | +8.6% | 340,000 | +70.0% | 0.09% | +33.8% |
Q2 2015 | $1,660,000 | – | 200,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Partners USVI, LLC | 152,500 | $697,000 | 2.61% |
Trellus Management Company, LLC | 155,800 | $712,000 | 0.90% |
WALL STREET ASSOCIATES | 942,200 | $4,306,000 | 0.40% |
BAILARD, INC. | 340,500 | $1,556,000 | 0.30% |
Baker Brothers Advisors | 2,608,271 | $11,920,000 | 0.17% |
STONERIDGE INVESTMENT PARTNERS LLC | 104,158 | $476,000 | 0.10% |
Cambridge Investment Research Advisors, Inc. | 449,080 | $2,052,000 | 0.09% |
BTG Pactual Global Asset Management Ltd | 33,700 | $154,000 | 0.03% |
HighTower Advisors, LLC | 242,001 | $1,106,000 | 0.03% |
BHF Kleinwort Benson Group S.A. | 39,000 | $178,000 | 0.02% |